000 03345nam a22004455i 4500
001 978-1-84628-015-3
003 DE-He213
005 20161121230556.0
007 cr nn 008mamaa
008 100301s2005 xxk| s |||| 0|eng d
020 _a9781846280153
_9978-1-84628-015-3
024 7 _a10.1007/b136185
_2doi
050 4 _aRC870-923.2
050 4 _aRC875-899.5
072 7 _aMJS
_2bicssc
072 7 _aMED088000
_2bisacsh
082 0 4 _a616.6
_223
245 1 0 _aUrological Cancers
_h[electronic resource] /
_cedited by Jonathan Waxman.
264 1 _aLondon :
_bSpringer London,
_c2005.
300 _aXVI, 342 p. 45 illus., 31 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aProstate Cancer -- The Molecular Biology of Prostate Cancer -- Familial Prostate Cancer -- Screening for Prostate Cancer -- Diet and Prostate Cancer -- Radical Radiotherapy for Prostate Cancer -- Prostate Cancer: Immediate vs. Deferred Treatment -- Surgical Treatment of Prostate Cancer -- Hormone Therapy for Prostate Cancer -- Chemotherapy in Prostate Cancer -- Proteomic Approaches to Problem Solving in Prostate Cancer -- Gene Therapy for Prostate Cancer -- Bladder Cancer -- Molecular Biology of Bladder Cancer -- Treatment Options in Superficial (pTA/pT1/CIS) Bladder Cancer -- Chemotherapy for Bladder Cancer -- Gene Therapy of Urothelial Malignancy -- Kidney Cancer -- Molecular Biology of Kidney Cancer -- Cytokine and Angiogenesis Inhibitors -- Novel Therapies for Renal Cell Cancer -- Testicular Cancer -- Genetics and Biology of Adult Male Germ Cell Tumors -- Chemotherapy for Testicular Cancer -- Surgery for Testicular Cancer -- Pathobiological Basis of Treatment Strategies of Germ Cell Tumors -- Penile Cancer -- A Scientific Understanding of the Development of Penile Tumors -- The Clinical Management of Penile Cancer -- Unusual Urological Tumors -- Oncocytomas and Rare Renal Tumors -- Small Cell Tumors, Lymphomas, and Sertoli Cell and Leydig Cell Tumors of the Bladder, Prostate, and Testis.
520 _aOur understanding of the scientific basis for urothelial malignancy has advanced significantly. Studies in prostate cancer, few and far between 20 years ago, have increased and the degree of Government intervention, both in Europe and America, to support work in this field has risen considerably. Interest within the pharmaceutical industry has grown as well, and this has led to the development of new treatment options for all of the urological malignancies and real improvements in remission rates and durations. This book outlines developments in all areas of urological cancer, bringing together, in one volume, summaries of clinical and molecular advances, which will be invaluable to urologists and oncologists.
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aUrology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aUrology.
650 2 4 _aOncology.
700 1 _aWaxman, Jonathan.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781852339111
856 4 0 _uhttp://dx.doi.org/10.1007/b136185
912 _aZDB-2-SME
950 _aMedicine (Springer-11650)
999 _c500803
_d500803